Research Archive
October 2021
Healthcare / Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact
View research noteSeptember 2021
Biopharma / Immuno-Oncology Round-up from ESMO 2021
View research noteAugust 2021
FT516 & FT596 in NHL Give 4 Strong, 3 Weak, and 5 Uncertain Signals
View research noteJuly 2021
VRTX / Seen This Movie Before? Another Biopharma Multiple Compression Saga, PT to $170 / Underperform
View research noteJune 2021
NTRA / Making Sense of the Signatera ADLT; Increasing Estimates, PT to $160 / Outperform
View research noteMay 2021
Life Science Tools and Diagnostics / Comparing Performance of Leading MRD Liquid Biopsy Tests as Early Data Emerges
View research noteApril 2021
Biopharma / Three DC Risks That Could Keep Biopharma Multiples Depressed All Year
View research noteMarch 2021
Life Science Tools and Diagnostics Volatility Creates Opportunities: Highlighting Winners Among the Crash Landing
View research noteFebruary 2021
Biopharma / 2021 MEDACorp IBD Physician Survey Shows Novel Orals Set to Expand Market
View research noteJanuary 2021
Biopharma / Biotech Financing in a COVID Year: Record Deal Flow, Record Capital Formation
View research noteDecember 2020
Biopharma / Vax Series #4: Shibboleths – Short-Lived Immunity, Vaccine Scarcity, Local Mfg.
View research noteNovember 2020